Omarigliptin-impurities | Pharmaffiliates

Omarigliptin

Omarigliptin used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co.Reference standards of Omarigliptin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Omarigliptin - API
    [catalogue_number] => PA 15 73000
    [category_ids] => ,79,80,69,81,78,70,82,88,
    [chemical_name] => 
    [weight] => 398.43
    [form] => C17H20F2N4O3S
    [cas] => 1226781-44-7
    [pslug] => 1226781-44-7-omarigliptin-api-pa1573000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 15 73000

Omarigliptin - API


  • Catalogue No.:PA 15 73000

  • CAS :

    1226781-44-7

  • Molecular Formula : C17H20F2N4O3S

  • Molecular Weight : 398.43